{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:00:13Z","timestamp":1783969213563,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":2472,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens","award":["GCIG006-1a"],"award-info":[{"award-number":["GCIG006-1a"]}]},{"name":"Merck"},{"name":"Lilly Deutschland GmbH, Bad Homburg, Germany"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council, UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1093\/annonc\/mds538","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T01:01:09Z","timestamp":1351299669000},"page":"937-943","source":"Crossref","is-referenced-by-count":34,"title":["A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"C.K.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Simes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Berton-Rigaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Skeie-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Parma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Ledermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pujade-Lauraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Belau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nankivell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Canzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kurzeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mds538_bb0010","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1200\/JCO.2004.04.095","article-title":"Cancer patient preferences for communication of prognosis in the metastatic setting","volume":"22","author":"Hagerty","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds538_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/bjc.2011.364","article-title":"Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer","volume":"105","author":"Lee","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds538_bb0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jnci\/djh081","article-title":"Re: new guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)","volume":"96","author":"Rustin","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds538_bb0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","article-title":"Staging of advanced ovarian cancer: comparison of imaging modalities\u2014report from the Radiological Diagnostic Oncology Group","volume":"215","author":"Tempany","year":"2000","journal-title":"Radiology"},{"key":"10.1093\/annonc\/mds538_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jnci\/djk091","article-title":"When you look matters: the effect of assessment schedule on progression-free survival","volume":"99","author":"Panageas","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds538_bb0035","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/jco.2011.29.15_suppl.5052","article-title":"Pegylated liposomal doxorubicin and carboplatin (C-PLD) versus paclitaxel and carboplatin (C-P) in platinum-sensitive ovarian cancer (OC) patients (pts): treatment at recurrence and overall survival (OS) final analysis from CALYPSO phase III GCIG trial","volume":"29","author":"Marth","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds538_bb0040","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG","volume":"24","author":"Pfisterer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds538_bb0045","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"The ICON and AGO Collaborators","year":"2003","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds538_bb0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Series B (Methodological)"},{"key":"10.1093\/annonc\/mds538_bb0055","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"key":"10.1093\/annonc\/mds538_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1536867X0200200103","article-title":"Parameters behind \u2018nonparametric\u2019 statistics: Kendall's tau, Somers\u2019 D and median differences","volume":"2","author":"Newson","year":"2002","journal-title":"Stata J"},{"key":"10.1093\/annonc\/mds538_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1093\/annonc\/mds538_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02295996","article-title":"Note on the sampling error of thee differences between correlated proportions or percentages","volume":"12","author":"McNemar","year":"1947","journal-title":"Psychometrika"},{"key":"10.1093\/annonc\/mds538_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2004.07.011","article-title":"Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer","volume":"95","author":"Gordon","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mds538_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2007.08.088","article-title":"The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer","volume":"108","author":"Carey","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mds538_bb0085","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1200\/JCO.2011.36.1329","article-title":"Prediction models: revolutionary in principle, but do they do more good than harm?","volume":"29","author":"Vickers","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds538_bb0090","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2001.19.4.980","article-title":"Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer","volume":"19","author":"Ravdin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds538_bb0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2007.12.7837","article-title":"Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials","volume":"26","author":"Korn","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds538_bb0100","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1200\/JCO.2009.25.5489","article-title":"Comparison of error rates in single-arm versus randomized phase II cancer clinical trials","volume":"28","author":"Tang","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds538_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ejca.2009.11.013","article-title":"Historical cross-trial comparisons for competing treatments in advanced breast cancer\u2014an empirical analysis of bias","volume":"46","author":"Lee","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mds538_bb0110","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/jama.279.21.1709","article-title":"Relationship between cancer patients\u2019 predictions of prognosis and their treatment preferences","volume":"279","author":"Weeks","year":"1998","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mds538_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.bjc.6602908","article-title":"Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer","volume":"94","author":"Stockler","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds538_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","article-title":"A systematic review of physicians\u2019 survival predictions in terminally ill cancer patients","volume":"327","author":"Glare","year":"2003","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/mds538_bb0125","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<170::AID-CNCR23>3.0.CO;2-S","article-title":"The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer","volume":"86","author":"Vigan\u00f2","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds538_bb0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/jme.2005.012427","article-title":"Individual survival time prediction using statistical models","volume":"31","author":"Henderson","year":"2005","journal-title":"J Med Ethics"},{"key":"10.1093\/annonc\/mds538_bb0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ncponc1178","article-title":"Gene-expression profiling in epithelial ovarian cancer","volume":"5","author":"Konstantinopoulos","year":"2008","journal-title":"Nat Clin Pract Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419371819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419371819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/4\/937\/13788673\/mds538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T20:53:49Z","timestamp":1714510429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419371819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0923753419371819"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds538","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}